Orostat Solution
- Manufacturer
- Gingi-Pak a Division of the Belport | Jeff Nichols
- Effective date
- 2026-06-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- monthly-update
- Hydrated at
- 2026-07-17 21:36:21
Label at a glance#
ProductOrostat 8%
Active ingredientEPINEPHRINE HYDROCHLORIDE
Label structure11 sections
Label contents#
Full prescribing information#
Purpose
Description
Inactive Ingredient
Keep out of reach if children
Storage
Uses
Do not use
Warnings
Directions
Principal Display-Orostat 8%
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0b4ec9ca-d305-43fc-88dd-7a510313efe0 | Product name | 1 | 20260105 |
| bb209f42-a85f-4fee-9d3d-c9dded168625 | Product name | 1 | 20251208 |
| 49628fc7-2031-4c28-bd31-0ef3aa8f44a3 | Product name | 3 | 20251118 |
| cbf85893-59ef-423f-87d4-a573c000a8b9 | Product name | 8 | 20250731 |
| b5b1095b-40cd-8a9e-b111-502545045b07 | Product name | 4 | 20250325 |
| e190029e-423b-473c-8e04-2ada59b5b711 | Product name | 1 | 20250314 |
| 777d68c6-a5ab-e06c-d314-677b0b9af0c8 | Product name | 2 | 20240508 |
| e0031c74-3853-42bc-8e10-86dbbe83992e | Product name | 2 | 20231116 |
| f7046b89-2016-499a-adc6-78479172abc6 | Product name | 1 | 20230425 |
| 2686d634-e712-4007-8dbf-3d37c6c4d71f | Product name | 1 | 20181121 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| bd49bb86-2d32-4a7a-a594-eeda2e29af42 | Product name | 1 | 20180118 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 4073022c-5d5d-48f5-82ed-091ad146a4b2 | Product name | 1 | 20171211 |
| 3becbe78-12d9-4ad2-9b4c-1e36f8d1303a | Product name | 1 | 20170815 |
| 9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5 | Product name | 1 | 20150828 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10129-006-02 | 2025-01-30 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
| 10129-006-02 | 2025-01-30 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
| 10129-006-02 | 2021-09-02 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
| 10129-006-02 | 2021-09-02 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
| 10129-006-02 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
| 10129-006-02 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-2457-fd44-e053-dadaa90aa01b | Orostat Solution |
Products#
Every source-derived product name is available through these pages.
- Orostat 8%
- EPINEPHRINE HYDROCHLORIDE
- EDETIC ACID
- METHYLPARABEN
- SODIUM CHLORIDE
- SODIUM DITHIONITE
- SODIUM THIOSULFATE
- SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
- PROPYLPARABEN
- BENZYL ALCOHOL
- EPINEPHRINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10129-006 | 10129-006-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| EDETIC ACID | 9G34HU7RV0 | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM DITHIONITE | 2K5B8F6ES1 | IACT |
| SODIUM THIOSULFATE | HX1032V43M | IACT |
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | KH7I04HPUU | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
| EPINEPHRINE HYDROCHLORIDE | WBB047OO38 | ACTIB |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2018-01-11 | full-release | 2026-05-31 22:56:48 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Orostat 8% | EPINEPHRINE HYDROCHLORIDE | Gingi-Pak a Division of the Belport | 755005b8-165b-b667-e053-2991aa0a3651 | 2026-06-26 | Warnings | 10129-006-02 10129-006 10129000602 552f7c53-4da9-8ebd-e063-6394a90a5632 755005b8-165b-b667-e053-2991aa0a3651 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.










